SCHEMBL7186887

SCHEMBL7186887

CCOc1ccc(PC(=O)c2c(C)cc(C)cc2C)cc1.[LiH]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
GAA P10253 2/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
MAPT P10636 1/20 0.41
PARP10 Q53GL7 1/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
SLC5A1 P13866 1/20 0.40
SLC5A2 P31639 1/20 0.40
NQO1 P15559 1/20 0.40
ITGB1 P05556 1/20 0.40
ITGA4 P13612 1/20 0.40
LTA4H P09960 1/20 0.39
NPC1 O15118 2/20 0.39
PLK1 P53350 1/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7181825 0.89 ITGB1 (0.46) ALDH1A1GAAMAPTSLC5A1SLC5A2
SCHEMBL7175082 0.89 ITGB1 (0.51) ITGB1ITGA4LTA4HCYP1A2SMN1; SMN2
SCHEMBL7181696 0.88 THRA (0.41) ITGB1ITGA4MEN1KMT2ATDP1
SCHEMBL7175718 0.88 EPHX2 (0.45) ALDH1A1GAAMAPTPARP10SLC5A1
SCHEMBL7188875 0.87 PARP10 (0.41) ALDH1A1GAAMAPTPARP10NQO1
SCHEMBL7179647 0.87 ITGB1 (0.55) ITGB1ITGA4LTA4H
SCHEMBL7190160 0.86 ALDH1A1 (0.39) ALDH1A1GAAPARP10SLC5A1SLC5A2
SCHEMBL7179956 0.85 ITGB1 (0.54) ITGB1ITGA4LTA4H
SCHEMBL7186832 0.85 ITGB1 (0.42) MAPTITGB1ITGA4NPC1TDP1
SCHEMBL7189254 0.85 FOS (0.39) GAAMAPTITGB1ITGA4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 ALDH1A1 3416/4885GAA 4753/4885HSP90AA1 3550/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 ALDH1A1 3984/4885GAA 4793/4885HSP90AA1 3630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.